4 assets in Acute Graft Versus Host Disease

Therapeutic assets addressing Acute Graft Versus Host Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lactobacillus Plantarum Strain 299V Acute Graft Versus Host Disease	Children's Oncology Group	P3	B (59)
Ruxolitinib Acute Graft Versus Host Disease	Xenikos	P3	B (59)
T-Guard Acute Graft Versus Host Disease	Xenikos	P3	B (57)
trx103 Acute Graft Versus Host Disease	Tr1X, Inc.	P1	NR ()